This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2012 Aug;62(2):242-4; discussion 244-5.

doi: 10.1016/j.eururo.2012.04.016. Epub 2012 Apr 13.

5α-reductase inhibitors: preventing the treatable

Robert J Hamilton, Gerald L Andriole, Stephen J Freedland

PMID: 22521654
DOI: 10.1016/j.eururo.2012.04.016

Editorial

5α-reductase inhibitors: preventing the treatable

Robert J Hamilton et al. Eur Urol. 2012 Aug.

. 2012 Aug;62(2):242-4; discussion 244-5.

doi: 10.1016/j.eururo.2012.04.016. Epub 2012 Apr 13.

Authors

Robert J Hamilton, Gerald L Andriole, Stephen J Freedland

PMID: 22521654
DOI: 10.1016/j.eururo.2012.04.016

No abstract available

PubMed Disclaimer

Comment on

Finasteride reduces the risk of incident clinical benign prostatic hyperplasia.
Parsons JK, Schenk JM, Arnold KB, Messer K, Till C, Thompson IM, Kristal AR; Prostate Cancer Prevention Trial; Urologic Diseases in America Project. Parsons JK, et al. Eur Urol. 2012 Aug;62(2):234-41. doi: 10.1016/j.eururo.2012.03.007. Epub 2012 Mar 14. Eur Urol. 2012. PMID: 22459892 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information